PATENT CLAIM ANALYSIS

Application Number: 15906350
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "304000"]

Abstract:
This invention relates to the use of pharmaceutical compositions comprising a therapeutically effective combination of Tesofensine and Metoprolol for preventing the cardiovascular side effects of Tesofensine, while leaving the robust inhibitory efficacy on food intake and body weight loss unaffected.

Claim (Index 16):
The method of  claim 1 , wherein the human is administered a pharmaceutically acceptable salt of Tesofensine and the pharmaceutically acceptable salt of Tesofensine is Tesofensine citrate.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 88.0
- Lexical Diversity: 1.16667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14936963', '14379032', '15058533', '15554449', '13061853']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8024418977348925
- 35 USC 102 Novelty (BERT): 0.654346675971366
- Combined Prediction Score: 0.7876323755585398
- Mean Citation Score: 486.28498
- Max Citation Score: 738.0185
- Similarity Product: 564.9238275529146

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test